DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Stanley TL, Fourman LT, Feldpausch MN. et al.
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial.
Lancet HIV 2019;
6 (12) e821-e830
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.